4Pharma strong in science and medical writing

Jouni Vuorinen (jouni.vuorinen a 4pharma.com), Sep 24th 2015

Two manuscripts with contribution by 4Pharma were recently accepted for publication:

  • Stiff PJ, Leinonen M, Kullenberg T, Rudebeck M, de Chateau M, Spielberger R. Long-term safety outcomes in patients with hematological malignancies undergoing autologous hematopoietic stem cell transplantation treated with palifermin to prevent oral mucositis. Will be published in Biology of Blood and Marrow Transplantation.
  • Kuoppamäki M, Leinonen M, Poewe W. Efficacy and safety of entacapone in levodopa/carbidopa versus levodopa/benserazide treated Parkinson’s disease patients with wearing-off. Will be published in Journal of Neural Transmission.

In addition, 4Pharma assisted in the medical writing of the following soon-to-be-published manuscript:

  • Kaarniranta K, Ikäheimo K, Mannermaa E, Ropo A. Pharmacokinetics, efficacy and safety of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% in healthy volunteers: A phase I comparison versus the corresponding preservative-free monotherapies. Will be published in Clinical Pharmacokinetics.